Injective (INJ) is 21.0× the size of Keeta (KTA) by market capitalisation. Their daily returns move barely together (correlation 0.25 across 54 shared trading days). Both have run at a similar volatility, around 96% annualised.
KTAINJ
0.25over 54 shared trading days
Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.
| Metric | KTA | INJ |
|---|---|---|
| Max drawdown (400d) | -43.3% | -79.5% |
| Risk-adjusted return (90d) | -0.28 | 0.46 |
| Best 30 days (past year) | — | +92.8% |
| Worst 30 days (past year) | — | -46.8% |
Relative strength over 90 days: INJ outperformed KTA by 51.2% — measured on the KTA/INJ ratio, so it holds regardless of market direction.